Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diquafosol Tetrasodium 2% in Dry Eye Disease
NCT00403975Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Jun 2004; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00403975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403975.